Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FQJV9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,140
Award facts
- Contract value 100% obligated
- $13,139.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,139.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The contract, issued as a firm fixed-price delivery order on January 7, 2026, with an ultimate completion date of January 29, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with demonstrated capability across a diverse portfolio including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's underlying IDC with the DLA, awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products and medical consumables to support recurring medical supply needs of military healthcare operations. The contractor maintains no identified subcontractors and has demonstrated consistent performance across numerous delivery orders issued by the DLA's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FQJV9?
SPE2DR26FQJV9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FQJV9 worth?
The government has obligated $13,140 on SPE2DR26FQJV9.
Is contract SPE2DR26FQJV9 an order under another contract?
Yes. SPE2DR26FQJV9 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJV9 competed?
The extent of competition for SPE2DR26FQJV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award